This report prioritises therapies that deliver government savings over those that benefit patients

The report recommends a seismic shift in decision-making that would deliver successive governments billions in new savings. In return, the industry, patients, clinicians, and other stakeholders secure more processes and complexity and the vaguely worded goal of funded access for a few therapies up to around one year after TGA approval and following two submissions. …